Clinical research teams accelerate progress in treatment options, CVRx asserts

Clinical research teams accelerate progress in treatment options, CVRx asserts
CVRx commends clinical researchers

CVRx recognizes the important role of researchers and healthcare professionals who advance the science underpinning better patient care.

The company emphasized that clinical trials are essential for expanding treatment options, improving medical outcomes, and deepening the understanding of diseases and therapies. CVRx expressed gratitude to those working in clinical research. Details are being clarified.

Earlier this year, CVRx announced that Humana will provide Medicare Advantage coverage for Barostim therapy, expanding access to approximately 5.2 million Americans (link). The company also reported a 20 percent increase in total revenue for the first quarter, with a 22 percent gain in U.S. operations (link). These developments come as CVRx continues to support clinical research in its field.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.